Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Posted on 24 March 201114 February 2020 by admin Morotti M, Valenzano Menada M, Venturini PL, Ferrero S. Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment. Expert Opin Drug Metab Toxicol 2011;7:707-720.https://www.tandfonline.com/doi/abs/10.1517/17425255.2011.570330?journalCode=iemt20